Lupin Pharmaceuticals Inc. recalls Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1
Lupin Pharmaceuticals recalls birth control pills with failed content uniformity tests. These pills may not deliver the correct hormone levels, risking ineffective contraception. Consumers should contact the manufacturer for details.
Lower-risk recall
Failed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity.
Contact the company & request your remedy
What happened, in plain English
Lupin Pharmaceuticals is recalling birth control pills that failed content uniformity tests. This means the pills might not contain the correct hormone levels, potentially making them ineffective for contraception. Read more at govinfonow.com/recall/37340-lupin-birth-control-pills-recall-failed-content-uniformity-test.
Source Summary by GovInfoNow · govinfonow.com/recall/37340-lupin-birth-control-pills-recall-failed-content-uniformity-test · Updated October 5, 2026 · FDA enforcement record: FDA #D-1056-2020
Cite this page
“Lupin Birth Control Pills Recall: Failed Content Uniformity Test.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37340-lupin-birth-control-pills-recall-failed-content-uniformity-test. Based on FDA recall #D-1056-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1056-2020%22&limit=1).
Why it’s dangerous
The pills failed content uniformity tests, meaning they might not contain the correct hormone levels. This could lead to ineffective contraception if the pills do not deliver the intended hormone doses.
Who’s affected
Women who have been prescribed these specific birth control pills by a healthcare provider. Those using the pills for contraception are most at risk of ineffective protection.
How to tell if you have this one
Check for the product name 'Levonorgestrel and Ethinyl Estradiol Tablets USP' with specific dosages (0.05mg/0.03mg, 0.075mg/0.04mg, or 0.125mg/0.03mg). The packaging includes 28 tablets in a wallet, with 3 wallets per carton (NDC 68180-857-11 or 68180-857-13).
- Brand
Lupin Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Status
Terminated- Distribution
Nationwide in the USA and Puerto Rico.
| Recall number | Product, codes & lots | Quantity | Class |
|---|---|---|---|
| D-1055-2020 | Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.; Lot #: L800915, Exp July 2020 | 1,712 cartons | Class III |
| D-1056-2020 | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-857-13); Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.; Lot #: L800951, Exp July 2020 | 9,897 cartons | Class II |
What to do — step by step
Contact Manufacturer
Reach out to Lupin Pharmaceuticals for specific instructions on how to handle the recalled pills.
Questions people ask
Are these pills safe to use?
The recall indicates the pills failed content uniformity tests, so they may not deliver the correct hormone levels. Use with caution.
What should I do if I have these pills?
Contact Lupin Pharmaceuticals for specific instructions on handling the recalled pills.
How can I tell if my pills are recalled?
Check the product name and specific dosages listed in the recall notice. The packaging includes 28 tablets in a wallet with 3 wallets per carton (NDC 68180-857-11 or 68180-857-13).
Contact Lupin Pharmaceuticals
We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1056-2020 — Lupin Pharmaceuticals Lupin Pharmaceuticals Hello, I own a Lupin Pharmaceuticals that is covered by recall D-1056-2020 from Lupin Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1056-2020 (March 9, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1056-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.